PFE Pfizer Inc.
PFE Pfizer Inc.
Healthcare · Drug Manufacturers - General
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $25.58 · VWAP $26.00 · +13.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster
Coverage
1 related campaign
PFE Price Structure
Loading timeframes…
Peers
Every watchlist PFE belongs to, members best 30-day change first — PFE highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@healthcare-scan
@healthcare
Pfizer's second-quarter results beat earnings expectations, helped by strong demand for its blood-thinner portfolio, per Reuters (Aug 4 news pull). The company also outlined an additional $2.5 billion in cost cuts to support margins amid ongoing post-pandemic revenue pressure.
full note →Against street estimates
How PFE's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
PFE research tape
40 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.